|
The Patented ECA Stack. The secret is out. Women discover the fat-burning power of a popular men's bodybuilding formula.
What overweight women have learned is that for years virtually every professional bodybuilder, informed fitness expert and successful personal trainer would tell you the same thing. Whether you want to accelerate the burning of excess body fat, boost your metabolic rate, heighten your thermogenic output or increase your energy level, there is nothing stronger or more effective than the "thermogenic cocktail" of Ephedra, Caffeine, and Aspirin (The E/C/A- Stack").
The Patented ECA Stack is the only E/C/A stack that has Patent No. 5,055460 right on the label. That is your assurance that the ECA Stack contains an effective amount of each Ephedra, Caffeine and Aspirin that is proven to reduce body fat in clinical studies. (Daly, P et al., Internationional Journal of Obesity, Feb, 1993, 17 [Supp.1], S73-S78; and Colker, D., et al., Journal of the American College of Nutrition, Vol. 16. No.5, p.501 [#116]).
Suggested Use: Take two capsules with a full glass of water, Three times per day: mornings, noon and early evening. Do not exceed 6 capsules per day. Not to exceed 12 weeks continuous use. NOTE: Jitters, anxiety, dry mouth or insomnia may occur during the first week of use only. Reducing number of capsules per day during the first week should eliminate these mild effects.
Warnings: If you are pregnant or nursing, or you are at risk or are being treated for high blood pressure, heart, liver thyroid or psychiatric disease, diabetes pernicious anemia, nervousness, headache, anxiety, depression, seizure disorder, stroke or difficulty in urination due to prostate enlargement. Consult your health care professional before use if you are taking mao inhibitor or any other prescription drug. Discontinue use and consult your health care professional if dizziness sleeplessness, tremors, nervousness, headache, heart palpitations or tingling sensations occur.
Not intended for use for persons under the age of 18.
|